Literature DB >> 6323422

Kinetic and spectroscopic studies of the interaction of copper with dopamine beta-hydroxylase.

D E Ash, N J Papadopoulos, G Colombo, J J Villafranca.   

Abstract

The question of the stoichiometry of copper bound to dopamine beta-hydroxylase and the number of copper atoms required for maximal activity was addressed in this study. Incubation of tetrameric enzyme from bovine adrenal medulla with 64Cu2+ followed by rapid gel filtration yielded an enzyme containing 8.3-8.9 mol of Cu/mol of tetramer. An identical stoichiometry was obtained by analysis of bound copper by atomic absorption methods. NMR and EPR were used to monitor titrations of the enzyme with Cu2+ and showed that the longitudinal relaxation rate of solvent water protons and the amplitude of the signal at g approximately 2 increased linearly up to a copper to protein ratio of approximately 8. Additional titrations also indicate that an enzyme-Cu2+-tyramine-CN- inhibitory complex was formed when 8 mol of Cu2+ are bound per mol of enzyme. The rate of inactivation of dopamine beta-hydroxylase by the mechanism-based inhibitor 2-Br-3-(p-hydroxyphenyl)-1-propene was measured and used as a method to follow enzymatic catalysis. An increase in rate was observed with increasing Cu2+ up to a protein to Cu2+ ratio of 8 Cu/tetramer. The rate becomes constant after this ratio is achieved. These data indicate that dopamine beta-hydroxylase specifically binds 8 mol of Cu/tetramer and that this stoichiometry is required for maximal activity.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6323422

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Evidence for substrate preorganization in the peptidylglycine α-amidating monooxygenase reaction describing the contribution of ground state structure to hydrogen tunneling.

Authors:  Neil R McIntyre; Edward W Lowe; Jonathan L Belof; Milena Ivkovic; Jacob Shafer; Brian Space; David J Merkler
Journal:  J Am Chem Soc       Date:  2010-11-02       Impact factor: 15.419

2.  Imino-oxy acetic acid dealkylation as evidence for an inner-sphere alcohol intermediate in the reaction catalyzed by peptidylglycine alpha-hydroxylating monooxygenase.

Authors:  Neil R McIntyre; Edward W Lowe; David J Merkler
Journal:  J Am Chem Soc       Date:  2009-07-29       Impact factor: 15.419

3.  Plausible molecular mechanism for activation by fumarate and electron transfer of the dopamine beta-mono-oxygenase reaction.

Authors:  D Shyamali Wimalasena; Samantha P Jayatillake; Donovan C Haines; Kandatege Wimalasena
Journal:  Biochem J       Date:  2002-10-01       Impact factor: 3.857

4.  ATP7A and ATP7B copper transporters have distinct functions in the regulation of neuronal dopamine-β-hydroxylase.

Authors:  Katharina Schmidt; Martina Ralle; Thomas Schaffer; Samuel Jayakanthan; Bilal Bari; Abigael Muchenditsi; Svetlana Lutsenko
Journal:  J Biol Chem       Date:  2018-10-19       Impact factor: 5.157

5.  Structural insight of dopamine β-hydroxylase, a drug target for complex traits, and functional significance of exonic single nucleotide polymorphisms.

Authors:  Abhijeet Kapoor; Manish Shandilya; Suman Kundu
Journal:  PLoS One       Date:  2011-10-20       Impact factor: 3.240

6.  The crystal structure of human dopamine β-hydroxylase at 2.9 Å resolution.

Authors:  Trine V Vendelboe; Pernille Harris; Yuguang Zhao; Thomas S Walter; Karl Harlos; Kamel El Omari; Hans E M Christensen
Journal:  Sci Adv       Date:  2016-04-08       Impact factor: 14.136

7.  A delicate balance: Iron metabolism and diseases of the brain.

Authors:  Dominic Hare; Scott Ayton; Ashley Bush; Peng Lei
Journal:  Front Aging Neurosci       Date:  2013-07-18       Impact factor: 5.750

8.  Copper regulates rest-activity cycles through the locus coeruleus-norepinephrine system.

Authors:  Tong Xiao; Cheri M Ackerman; Elizabeth C Carroll; Shang Jia; Adam Hoagland; Jefferson Chan; Bao Thai; Christine S Liu; Ehud Y Isacoff; Christopher J Chang
Journal:  Nat Chem Biol       Date:  2018-06-04       Impact factor: 15.040

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.